Helps maintain a healthy weight GLP-1 is the un-hunger hormone that sends a message to your brain that youre full
Both reach therapeutic benefit eventually
This structured progression allows the body to adapt to the medication while minimizing gastrointestinal side effects that can occur with rapid dose increases
Notably, retatrutide trials showed an overwhelming clearance of liver fat, with some cohorts experiencing up to an 80% reduction in hepatic lipid content, presenting a massive benefit for individuals dealing with metabolic dysfunction-associated steatotic liver disease (MASLD)
Adverse Reactions Clinical Trials Experience The most commonly reported adverse reactions are hypersensitivity (e.g., rash, urticaria) reactions due to the effect of GH (e.g., arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome), injection site reactions (injection site erythema, pruritis, pain, urticaria, irritation, swelling, hemorrhage)
Both medications mimic the GLP-1 hormone, but Zepbound also mimics a second hormone: GIP